{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:11:32Z","timestamp":1761948692736,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11938-003-0012-y","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T18:13:45Z","timestamp":1180894425000},"page":"113-121","source":"Crossref","is-referenced-by-count":19,"title":["Liver transplantation for cholestatic liver disease"],"prefix":"10.1007","volume":"6","author":[{"given":"James","family":"Neuberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/jlts.2002.31345","volume":"8","author":"J Ratcliffe","year":"2002","unstructured":"Ratcliffe J, Longworth L, Young T, et al.: Cost Effectiness of Liver Transplantation Team. Assessing healthrelated quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl 2002, 8:263\u2013267.","journal-title":"Liver Transpl"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/lt.500050404","volume":"5","author":"DM Bravata","year":"1999","unstructured":"Bravata DM, Olkin I, Barnato AE, et al.: Health-related quality of life after liver transplantation: a metaanalysis. Liver Transpl Surg 1999, 5:318\u2013331.","journal-title":"Liver Transpl Surg"},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510280102","volume":"28","author":"MG Swain","year":"1998","unstructured":"Swain MG, Le T: Chronic cholestasis in rats induces anhedonia and a loss of social interest. Hepatology 1998, 28:6\u201310.","journal-title":"Hepatology"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00042737-200111000-00022","volume":"13","author":"J Neuberger","year":"2001","unstructured":"Neuberger J, Jones EA: Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Eur J Gastroenterol Hepatol 2001, 13:1393\u20131394.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11938-001-0019-1","volume":"4","author":"MJ Krowka","year":"2001","unstructured":"Krowka MJ: Hepatopulmonary syndrome and portopulmonary hypertension. Curr Treat Options Gastroenterol 2001, 4:539\u2013545. An excellent review on the diagnosis and management of these disorders in liver transplant candidates.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0168-8278(00)00108-2","volume":"34","author":"GP Martinez","year":"2001","unstructured":"Martinez GP, Barbera JA, Visa J, et al.: Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001, 34:651\u2013657.","journal-title":"J Hepatol"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007890-200108270-00018","volume":"72","author":"GR Stephenson","year":"2001","unstructured":"Stephenson GR, Moretti EW, El-Moalem H, et al.: Malnutrition in liver transplant candidates: preoperative global assessment is predictive of outcome after liver transplantation. Transplantation 2001, 72:666\u2013670.","journal-title":"Transplantation"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/jlts.2001.25879","volume":"7","author":"RH Wiesner","year":"2001","unstructured":"Wiesner RH, McDiarmid SV, Kamath PS, et al.: MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001, 7:567\u2013580. This article explains the basis of the scoring system and its role in the allocation of livers that underpins the North American system.","journal-title":"Liver Transpl"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-8278(99)80075-0","volume":"30","author":"E Christensen","year":"1999","unstructured":"Christensen E, Gunson B, Neuberger J: Optimal timing of liver transplantation for patients with primary biliary cirrhosis: use of prognostic modeling. J Hepatol 1999, 30:285\u2013292.","journal-title":"J Hepatol"},{"key":"12_CR10","first-page":"1285","volume":"92","author":"P Marchesa","year":"1997","unstructured":"Marchesa P, Lashner BA, Lavery IC, et al.: The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997, 92:1285\u20131288.","journal-title":"Am J Gastroenterol"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","volume":"7","author":"M Shimoda","year":"2001","unstructured":"Shimoda M, Farmer DG, Colquhoun SD, et al.: Liver transplantation for cholangiocellular carcinoma: analysis of a single center experience and review of the literature. Liver Transpl 2001, 7:1023\u20131033.","journal-title":"Liver Transpl"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","volume":"56","author":"E Siqueira","year":"2002","unstructured":"Siqueira E, Schoen RE, Silverman W, et al.: Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002, 56:40\u201347.","journal-title":"Gastrointest Endosc"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","volume":"19","author":"E Bjornsson","year":"1999","unstructured":"Bjornsson E, Kilander A, Olsson R: CA-19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with sclerosing cholangitis. Liver 1999, 19:501\u2013508.","journal-title":"Liver"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","volume":"6","author":"I Vreede De","year":"2000","unstructured":"De Vreede I, Steers JL, Burch PA, et al.: Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemotherapy for cholangiocarcinoma. Liver Transpl 2000, 6:309\u2013316. One of the first papers to suggest that intensive therapy can affect the outcome of cholangiocarcinoma and make such patients candidates for liver transplantation.","journal-title":"Liver Transpl"},{"key":"12_CR15","unstructured":"European Liver Transplant Registry: www.eltr.org. Accessed on January 27, 2003."},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(95)91797-7","volume":"346","author":"D Candinas","year":"1995","unstructured":"Candinas D, Gunson BK, Nightingale P, et al.: Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995, 346:1117\u20131121.","journal-title":"Lancet"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","volume":"29","author":"CR Gross","year":"1999","unstructured":"Gross CR, Malinchoc M, Kim WR, et al.: Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology 1999, 29:356\u2013364.","journal-title":"Hepatology"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/jlts.2002.31743","volume":"8","author":"M Aadahl","year":"2002","unstructured":"Aadahl M, Hansen BA, Kirkegaard P, Greenvold M: Fatigue and physical function after orthotopic liver transplantation. Liver Transpl 2002, 8:251\u2013259. This study suggests that fatigue may not resolve after liver replacement.","journal-title":"Liver Transpl"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","volume":"33","author":"RF Lindemann Garcia","year":"2001","unstructured":"Lindemann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J: Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001, 33:22\u201327. A large series looking at the outcome, risk factors, and disease recurrence in a single center.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"12_CR20","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1053\/jlts.2001.28514","volume":"7","author":"TW Faust","year":"2001","unstructured":"Faust TW: Recurrent primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatits after transplantation. Liver Transpl 2001, 7(Suppl 1):S99-S108.","journal-title":"Liver Transpl"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","volume":"360","author":"A Vera","year":"2002","unstructured":"Vera A, Moledina S, Gunson BK, et al.: Colectomy protects the liver allograft from recurrence of primary sclerosing cholangitis. Lancet, 2002, 360:1943\u20131944.","journal-title":"Lancet"},{"key":"12_CR22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/gut.43.5.639","volume":"43","author":"GV Papatheoridis","year":"1998","unstructured":"Papatheoridis GV, Hamilton M, Mistry PK, et al.: Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 1998, 43:639\u2013644.","journal-title":"Gut"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","volume":"134","author":"BY Tung","year":"2001","unstructured":"Tung BY, Emond MJ, Haggitt RC, et al.: Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001, 134:89\u201395. One of several publications suggesting an additional role for UDCA in reducing the risk of colonic polyps and cancers in those with cholestatic liver disease.","journal-title":"Ann Intern Med"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-003-0012-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0012-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:58Z","timestamp":1559437018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-003-0012-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s11938-003-0012-y","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"type":"print","value":"1092-8472"},{"type":"electronic","value":"1534-309X"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}